marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-13-2023
Orchard Therapeutics plc Financial Ratios 2011-2024 | ORTX
Annual Financial Ratios Orchard Therapeutics plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.5 | -1.1 | -3.8 | -7.4 | -1.2 | - | - | - | - | - | - | - |
P/S |
29.7 | 97.7 | 220.8 | 479.4 | 133.6 | - | - | - | - | - | - | - |
EPS |
-1.2 | -1.2 | -1.5 | -1.8 | -10.2 | -4.5 | -2.7 | - | - | - | - | - |
EV (Enterprise Value) |
724 M | 220 M | 620 M | 1.29 B | -3.89 M | 10.9 M | 20.8 M | - | - | - | - | - |
EBITDA per Share |
-0.97 | -1.11 | -1.55 | -1.84 | -10.4 | - | - | - | - | - | - | - |
EV/EBITDA |
-1.3 | -3.5 | -7.1 | 0.3 | - | - | - | - | - | - | - | |
PEG |
- | -0.3 | -0.09 | 0.01 | - | - | - | - | - | - | - | |
P/B |
6.8 | 0.8 | 3.2 | 4.0 | 0.9 | - | - | - | - | - | - | - |
P/CF |
-8.8 | -1.3 | -4.1 | -7.1 | -2.7 | - | - | - | - | - | - | - |
ROE % |
-153.32 | -68.87 | -85.17 | -54.62 | -74.03 | - | - | - | - | - | - | - |
ROA % |
-68.82 | -44.84 | -54.10 | -40.93 | -62.97 | - | - | - | - | - | - | - |
ROCE % |
-129.33 | -66.89 | -68.44 | -50.34 | -73.88 | - | - | - | - | - | - | - |
Current Ratio |
1.8 | 2.9 | 4.3 | 6.3 | 7.4 | - | - | - | - | - | - | - |
DSO |
80.1 | 256.9 | 3237.7 | 2378.5 | 2239.6 | - | - | - | - | - | - | - |
DIO |
146.0 | 2165.0 | 283.2 | - | - | - | - | - | - | - | - | - |
DPO |
520.9 | 15206.4 | 3757.8 | 5433.7 | 15676.8 | - | - | - | - | - | - | - |
Operating Cycle |
226.1 | 2421.9 | 3521.0 | 2378.5 | 2239.6 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-294.8 | -12784.6 | -236.8 | -3055.2 | -13437.3 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Orchard Therapeutics plc
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.15 | -0.07 | -0.12 | - | -0.37 | -0.4 | -0.35 | - | -0.29 | -290 | -0.31 | -0.34 | -200 | -480 | -0.51 | -0.46 | -0.38 | -0.56 | -0.35 | -0.42 | -3.29 | -15.45 | -1.53 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.12 | -0.18 | - | - | -0.25 | -0.29 | - | -0.25 | -0.28 | -0.3 | -0.39 | -0.25 | -0.47 | -0.45 | -0.5 | -0.42 | -0.6 | -0.32 | -0.49 | -3.27 | -15.6 | -1.36 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-110.87 | -105.32 | -128.84 | -98.48 | -113.58 | -90.24 | -69.27 | -40.85 | -59.70 | -55.96 | -68.74 | -85.17 | -81.51 | -82.42 | -72.69 | -54.62 | -47.49 | -61.13 | -1103.74 | -1113.12 | -1105.07 | -1079.15 | -19.66 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-51.11 | -53.97 | -63.86 | -50.71 | -60.96 | -35.69 | -45.73 | -29.33 | -41.29 | -38.27 | -45.14 | -54.10 | -53.50 | -55.48 | -51.23 | -40.93 | -36.40 | -27.20 | -14.55 | -6.85 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-94.03 | -87.70 | -89.19 | -64.17 | -77.81 | -70.86 | -62.30 | -39.13 | -60.92 | -62.02 | -74.64 | -87.98 | -82.58 | -81.68 | -73.54 | -57.78 | -50.65 | -62.88 | -1119.06 | -1127.19 | -1117.93 | -1091.86 | -17.59 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.7 | 1.9 | 1.9 | 1.8 | 2.1 | - | 2.5 | 2.9 | 3.1 | 3.6 | 4.2 | 2.7 | 2.7 | 2.7 | 2.7 | 4.0 | 4.0 | 4.0 | 4.0 | 6.7 | - | - | - | 8.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
113.9 | - | - | - | 33.4 | 42.9 | 46.1 | - | 41.1 | - | - | - | 40.1 | 134.2 | - | 221.2 | 68.6 | - | - | 139.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
354.9 | 260.4 | 1113.3 | - | 64.7 | 73.2 | 110.8 | - | 660.4 | - | - | - | 91.0 | 317.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
277.4 | 327.7 | 2248.9 | - | 180.8 | 400.7 | 576.8 | - | 2546.9 | - | - | - | 1207.0 | 4215.2 | - | - | 1781.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
468.8 | 260.4 | 1113.3 | - | 98.2 | 116.0 | 156.9 | - | 701.4 | - | - | - | 131.1 | 451.9 | - | 221.2 | 68.6 | - | - | 139.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
191.4 | -67.3 | -1135.7 | - | -82.6 | -284.7 | -419.9 | - | -1845.5 | - | - | - | -1076.0 | -3763.3 | - | 221.2 | -1712.4 | - | - | 139.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency